Optimizing Topical Axillary Perspiration Control Zoe Diana Draelos, MD
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Antiperspirants and Breast Cancer Risk
cancer.org | 1.800.227.2345 Antiperspirants and Breast Cancer Risk For some time, an email rumor suggested that underarm antiperspirants cause breast cancer1. Among its claims: ● Cancer-causing substances in antiperspirants are absorbed through razor nicks from underarm shaving. These substances are said to be deposited in the lymph nodes under the arm, which are not able to get rid of them by sweating because the antiperspirant keeps you from perspiring. This causes a high concentration of toxins, which leads to cells mutating into cancer. ● Most breast cancers develop in the upper outer quadrant of the breast because that area is closest to the lymph nodes exposed to antiperspirants. (Think of the breast as a circle divided by vertical and horizontal lines that cross at the nipple. Each of the 4 sectors you divide the breast into is called a quadrant. The upper outer quadrant of each breast is the part closest to the arm pit.) ● Men have a lower risk of breast cancer because they do not shave their underarms, and their underarm hair keeps chemicals in antiperspirants from being absorbed. All of these claims are largely untrue. Do antiperspirants increase a person's risk of breast cancer? There are no strong epidemiologic studies in the medical literature that link breast cancer risk and antiperspirant use, and very little scientific evidence to support this claim. In fact, a carefully designed epidemiologic study of this issue published in 2002 compared 813 women with breast cancer and 793 women without the disease. The researchers found no link between breast cancer risk and antiperspirant use, deodorant 1 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 use, or underarm shaving. -
Antiperspirants and Deodorants Regulation 1 Final Regulation Order REGULATION for REDUCING VOLATILE ORGANIC COMPOUND EMISSIONS F
Final Regulation Order REGULATION FOR REDUCING VOLATILE ORGANIC COMPOUND EMISSIONS FROM ANTIPERSPIRANTS AND DEODORANTS SUBCHAPTER 8.5. CONSUMER PRODUCTS Article 1. Antiperspirants and Deodorants 94500. Applicability. Except as provided in Section 94503, this article shall apply to any person who sells, supplies, offers for sale, or manufactures antiperspirants or deodorants for use in the state of California. NOTE: Authority cited: Sections 39600, 39601, and 41712, Health and Safety Code. Reference: Sections 39002, 39600, 40000, and 41712, Health and Safety Code. Amend title 17, California Code of Regulations, section 94501 as follows: 94501. Definitions. For the purpose of this article, the following definitions apply: (a) “Aerosol Product” means a pressurized spray system that dispenses antiperspirant or deodorant ingredients. (b) “Antiperspirant” means any product including, but not limited to, aerosols, roll-ons, sticks, pumps, pads, creams, and squeeze-bottles, that is intended by the manufacturer to be used to reduce perspiration in the human axilla by at least 20 percent in at least 50 percent of a target population. (c) “Colorant” means any substance or mixture of substances, the primary purpose of which is to color or modify the color of something else. (d) “Deodorant” means: 1) for products manufactured before January 1, 2006: any product including, but not limited to, aerosols, roll-ons, sticks, pumps, pads, creams, and squeeze-bottles, that is intended by the manufacturer to be used to minimize odor in the human axilla by retarding the growth of bacteria which cause the decomposition of perspiration. 2) for products manufactured on or after January 1, 2006: any product including, but not limited to, aerosols, roll-ons, sticks, Antiperspirants and 1 Deodorants Regulation pumps, pads, creams, and squeeze-bottles, that indicates or depicts on the container or packaging, or on any sticker or label affixed thereto, that the product can be used on or applied to the human axilla to provide a scent and/or minimize odor. -
Petition of the Procter & Gamble Company for Approval of Proposed Divestiture
PUBLIC RECORD VERSION UNITED STATES OF AMERICA BEFÖRE FEDERAL TRADE COMMISSION COMMISSIONERS: Deborah Platt Majoras, Chairman Pamela Jones Harbour Jon Leibowitz Wiliam E. Kovacic J. Thomas Rosch ) In the Matter of ) ) THEa corporation;PROCTER & GAMBLE COMPANY, ) ) ) Docket No. C-4151 and ) File No. 051-0115 ) THE GILLETTE COMPANY, ) a corporation., ) ) ) PETITION OF THE PROCTER & GAMBLE COMPANY FOR APPROVAL OF PROPOSED DIVESTITURE Pursuant to Section 2.41(f) of the Federal Trade Commission ("Commission" or "FTC") Rules of Practice and Procedure, 16 CF.R. § 2.41(f) (2005), and Paragraph II.A. of the final Decision and Order approved by the Commission in the above-captioned matter, The Procter & Gamble Company ("P&G") hereby fies this Petition for Approval of Proposed Divestitue ("Petition") requesting the Commission's approval of the divestitue of the APDO business, including Right Guard, Soft & Dri, Dry Idea, Natrel Plus, and Balance ("the APDO Assets") of The Gilette Company ("Gilette"), to The Dial Corporation ("Dial"), a subsidiar of Henkel KGaA ("Henkel"). .~ PUBLIC RECORD VERSION I. INTRODUCTION On September 23,2005, P&G and the Commission entered into an Agreement Containing Consent Orders, including an initial Decision and Order and an Order to Maintain Assets. On October 1,2005, pursuant to an Agreement and Plan of Merger between P&G and Gilette dated Januar 27, 2005, P&G completed its acquisition of Gilette. After a period of public comment, on December 15, 2005, the Commission issued its final Decision and Order , ("Order") (with minor changes) and Order to Maintain Assets (without changes) (collectively, the "Consent Agreement"). At the same time it reissued its Complaint (also without changes). -
Long-Lasting Muscle Thinning Induced by Infrared Irradiation Specialized with Wavelengths and Contact Cooling: a Preliminary Report
Long-Lasting Muscle Thinning Induced by Infrared Irradiation Specialized With Wavelengths and Contact Cooling: A Preliminary Report Yohei Tanaka, MD, Kiyoshi Matsuo, MD, PhD, and Shunsuke Yuzuriha, MD, PhD Department of Plastic and Reconstructive Surgery, Shinshu University School of Medicine, Matsumoto, Nagano 390-8621, Japan Correspondence: [email protected] Published May 28, 2010 Objective: Infrared (IR) irradiation specialized with wavelengths and contact cooling increases the amount of water in the dermis to protect the subcutaneous tissues against IR damage; thus, it is applied to smooth forehead wrinkles. However, this treatment consistently induces brow ptosis. Therefore, we investigated whether IR irradiation induces muscle thinning. Methods: Rat central back tissues were irradiated with the specialized IR device. Histological evaluation was performed on sagittal slices that included skin, panniculus carnosus, and deep muscles. Results: Significant reductions in panniculus carnosus thickness were observed between controls and irradiated tissues at postirradiation day 30 (P30), P60, P90, and P180; however, no reduction was observed in nonirradiated controls from days 0 to 180. No significant changes were observed in the trunk muscle over time. From day 0, dermal thickness was significantly reduced at P90 and P180; however, no difference was observed between P180 and nonirradiated controls at day 180. DNA degradation consistent with apoptosis was detected in the panniculus carnosus at P7 and P30. Conclusions: We found that IR irradiation induced long-lasting superficial muscle thinning, probably by a kind of apoptosis. The panniculus carnosus is equivalent to the superficial facial muscles of humans; thus, the changes observed here reflected those in the frontalis muscle that resulted in brow ptosis. -
UNITED STATES DISTRICT COURT for the SOUTHERN DISTRICT of OHIO RODNEY COLLEY (On Behalf of Himself and All Others Similarly Situ
Case: 2:16-cv-00225-MHW-KAJ Doc #: 1 Filed: 03/11/16 Page: 1 of 27 PAGEID #: 1 UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF OHIO RODNEY COLLEY (on behalf of himself ) CASE NO. and all others similarly situated) ) 3303 Wooden Valley Ct. ) JUDGE: Alexandria, Virginia 22310 ) ) Plaintiff, ) ) v. ) ) CLASS ACTION COMPLAINT PROCTER & GAMBLE CO. ) D/B/A/ OLD SPICE ) (Jury Demand Endorsed Hereon) c/o CT CORPORATION SYSTEM ) 1300 East Ninth Street ) Cleveland, Ohio 44114 ) ) and ) ) JOHN DOES 1-10 ) ) Defendants. ) ) Now comes Rodney Colley (“Plaintiff”), by and through undersigned counsel, for himself individually and as class representative for a class of similarly situated individuals, and alleges upon personal knowledge and information and belief, the following: Case: 2:16-cv-00225-MHW-KAJ Doc #: 1 Filed: 03/11/16 Page: 2 of 27 PAGEID #: 2 INTRODUCTION 1. This is a consumer protection claim, which is ideal for class certification.1Plaintiff on behalf of himself and as class representative for a class of similarly situated individuals defined below, brings suit to seek redress for violations of Ohio’s Product Liability Act, Ohio’s Consumer Sales Practices Act, breach of implied warranty of merchantability and unjust enrichment. Plaintiff and all Class members have been and continue to be injured by Procter & Gamble, Co.’s, d/b/a Old Spice’s (hereinafter “P&G” or “Old Spice”), pattern and practice of placing into the stream of commerce dangerous products. Namely Old Spice deodorant, which regularly and routinely causes rashes, irritation, burning and other injury to unsuspecting customers (“the Product”). -
Formulation and Effectivity Test of Deodorant from Activated Charcoal of Palm Shell As Excessive Sweat Adsorbent on Body
Online - 2455-3891 Vol 12, Issue 10, 2019 Print - 0974-2441 Research Article FORMULATION AND EFFECTIVITY TEST OF DEODORANT FROM ACTIVATED CHARCOAL OF PALM SHELL AS EXCESSIVE SWEAT ADSORBENT ON BODY UCE LESTARI1*, FAIZAR FARID2, AHMAD FUDHOLI3 1Pharmaceutical Study Program, Faculty of Science and Technology University of Jambi, Jambi, Indonesia. 2Chemical Study Program, Faculty of Science and Technology University of Jambi, Jambi, Indonesia. 3Department of Physics Engineering, Solar Energy Research Institute, Universiti Kebangsaan Malaysia, 43600 Bangi Selangor, Malaysia. Email: [email protected] Received: 08 April 2019, Revised and Accepted: 23 August 2019 ABSTRACT Objective: The objective of this study was to know the physically stable deodorant preparations during storage and to obtain the preparations. Methods: The evaluation of the physical properties of deodorant include: Organoleptic test, homogeneity, pH measurement, viscosity, flow properties, drying time, moisture content, flow time, density, cycling test, hedonic test, irritation test, and effectivity test of sweat adsorption. Activated charcoal used by the formulation of deodorant powder and roll on each with a concentration of 15%. Results: The physicochemical evaluation was obtained. Descriptively produced data stated that deodorant powder is more physically stable that deodorant roll-on which has separated during storage. Conclusion: For the effectivity of sweat adsorption, deodorant powder is more effective than deodorant roll-on. Keywords: Deodorant, Activated charcoal, Palm shell, Sweat. © 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2019.v12i10.33490 INTRODUCTION from that used to adsorb excessive sweats in the body that interfere daily activity and lower confidence [8]. -
Table S1. Checklist for Documentation of Google Trends Research
Table S1. Checklist for Documentation of Google Trends research. Modified from Nuti et al. Section/Topic Checklist item Search Variables Access Date 11 February 2021 Time Period From January 2004 to 31 December 2019. Query Category All query categories were used Region Worldwide Countries with Low Search Excluded Volume Search Input Non-adjusted „Abrasion”, „Blister”, „Cafe au lait spots”, „Cellulite”, „Comedo”, „Dandruff”, „Eczema”, „Erythema”, „Eschar”, „Freckle”, „Hair loss”, „Hair loss pattern”, „Hiperpigmentation”, „Hives”, „Itch”, „Liver spots”, „Melanocytic nevus”, „Melasma”, „Nevus”, „Nodule”, „Papilloma”, „Papule”, „Perspiration”, „Petechia”, „Pustule”, „Scar”, „Skin fissure”, „Skin rash”, „Skin tag”, „Skin ulcer”, „Stretch marks”, „Telangiectasia”, „Vesicle”, „Wart”, „Xeroderma” Adjusted Topics: "Scar" + „Abrasion” / „Blister” / „Cafe au lait spots” / „Cellulite” / „Comedo” / „Dandruff” / „Eczema” / „Erythema” / „Eschar” / „Freckle” / „Hair loss” / „Hair loss pattern” / „Hiperpigmentation” / „Hives” / „Itch” / „Liver spots” / „Melanocytic nevus” / „Melasma” / „Nevus” / „Nodule” / „Papilloma” / „Papule” / „Perspiration” / „Petechia” / „Pustule” / „Skin fissure” / „Skin rash” / „Skin tag” / „Skin ulcer” / „Stretch marks” / „Telangiectasia” / „Vesicle” / „Wart” / „Xeroderma” Rationale for Search Strategy For Search Input The searched topics are related to dermatologic complaints. Because Google Trends enables to compare only five inputs at once we compared relative search volume of all topics with topic „Scar” (adjusted data). Therefore, -
There Are 25 Questions, Each Worth 3 Points and a Short Essay Worth 25 Points. DO YOUR OWN WORK !! Use Your Time Wisely 1. T
Mr. Holder Integumentary System – Unit 5 December 3, 2015 ARC TEST 1.0 DO NOT MARK OR WRITE ON THIS QUIZ !! There are 25 questions, each worth 3 points and a short essay worth 25 points. DO YOUR OWN WORK !! Use Your Time Wisely 1. The Integumentary System is divided into how many layers? a) 2 b) 3 c) 4 d) 6 2. What are the two major groups of membranes covering the human body? a) Epithelial & Mucus b) Cutaneous & Mucus c) Epithelial & Connective Tissue d) None of these 3. Which internal membrane provides protection for your joints? a) Serous b) Synovial c) Cutaneous d) Mucus 4. These membranes line internal cavities exposed to air & excrete a gooey substance. a) Serous b) Synovial c) Cutaneous d) Mucus 5. The Integumentary System protects the human body from … a) Friction b) Hot & Cold Temperature c) Bacteria d) All of These 6. Which stratum of the epidermis is full of keratin, cornified to prevent water loss? a) Basale b) Granulosum c) Corneum d) None of These 7. Which body system extends into the dermis to provide information to your brain? a) Cardiovascular b) Immune c) Integumentary d) Nervous 8. Subcutaneous tissue includes adipose tissue or fat. It is also known as the … a) Dermis b) Papillary Layer c) Hypodermis d) Reticular Layer 9. The dermis is divided into two layers. Which of these is the thickest? a) Papillary b) Reticular c) Basale d) Hypodermis 10. Which stratum of the epidermis is responsible for new cell production? a) Corneum b) Basale c) Granulosum d) Spinosum Page 1 Mr. -
Infection of Human Sweat Glands by SARS-Cov-2 Jia Liu1,Yufengli1,Liangliu2,Xudonghu3,Xiwang1, Hengrui Hu1, Zhihong Hu 1,Yiwuzhou2 and Manli Wang 1
Liu et al. Cell Discovery (2020) 6:84 Cell Discovery https://doi.org/10.1038/s41421-020-00229-y www.nature.com/celldisc CORRESPONDENCE Open Access Infection of human sweat glands by SARS-CoV-2 Jia Liu1,YufengLi1,LiangLiu2,XudongHu3,XiWang1, Hengrui Hu1, Zhihong Hu 1,YiwuZhou2 and Manli Wang 1 Dear Editor, detected in the epidermis or sebaceous glands (Supple- Severe acute respiratory syndrome coronavirus 2 mentary Fig. S1b). (SARS-CoV-2) induces multiorgan dysfunction by ram- Sweat glands comprise the inner secretory luminal and paging throughout the body1,2. As dermatological lesions outer myoepithelial cell layers, while sweat ducts com- affect 1%–20% of patients with coronavirus disease 2019 prise epithelial and basal cells6. To explore the details of (COVID-19)3, the skin may not be exempt. Skin biopsy SARS-CoV-2 cell tropism, colocalization analysis of viral samples reportedly have low SARS-CoV-2 loads4,5; how- spike proteins and individual cell markers was performed. + ever, it remains unclear whether SARS-CoV-2 directly In sweat glands, the keratin (Krt) 7 secretory luminal causes cutaneous manifestations, and if so, what is the cell cells were found to be major target cells for SARS-CoV-2 + tropism of the virus in the skin and whether skin contact infection, whereas the Krt5 cells/alpha smooth muscle + poses a risk of viral transmission. actin (α-SAM) myoepithelial cells were not infected To explore these issues, we obtained skin autopsy (Supplementary Fig. S2a, the middle panel). In sweat − − + samples from five patients with COVID-19. Although they ducts, some Krt5 /Krt7 epithelial cells, but not Krt5 had no clinical dermatological manifestations (Supple- basal cells, were infected (Supplementary Fig. -
Dermofeel® TEC Eco
Product Information dermofeel® TEC eco The Product: dermofeel® TEC eco dermofeel® TEC eco is a colorless and odorless lipophilic liquid made from natural resources. It is an ideal addition in deodorant formulations because it inhibits the esterase-based metabolism of sweat components which cause malodor. CHARACTERISTICS - INCI: Triethyl citrate - Appearance: colorless liquid - 100% naturally derived; COSMOS approved and compliant with other standards for natural cosmetic; please contact us for further information - Manufactured by esterification of plant based ethanol with citric acid, deriving from glucose syrup by fermentation process from corn starch and/or sugar beet - Well known lipophilic substance - Good solvating properties - Excellent additive for deodorant formulations - Will inhibit the formation of malodor from sweat - Easy to use liquid - Suitable for emulsions and aqueous based formulations - Water solubility: 65 g/l (at 25°C) DOSAGE Product Concept Dosage All product types 1.0 – 5.0 % Evonik Dr. Straetmans GmbH | dermofeel® TEC eco | November 2019 1/4 How to work with dermofeel® TEC eco MANUFACTURING PROCEDURE (LABORATORY SCALE) In emulsions Add dermofeel® TEC eco to the oil phase and proceed as usual. In surfactant based formulations 1. Dissolve dermofeel® TEC eco with the surfactant mixture. 2. At the end of the formulation process, adjust viscosity Note: dermofeel® TEC eco is a lipophilic substance and may influence viscosity built up, depending on the surfactant combination. In aqueous based formulations 1. Dissolve dermofeel® TEC eco with the help of a solubilizer. 2. Mix with the water phase and proceed as usual. FORMULATION ADVICE pH drift in emulsions Use a pH buffer (e.g. -
After Lumpectomy
Breast Center After Lumpectomy A lumpectomy, also called a partial mastectomy and breast conservation surgery, removes the breast tumor and a rim of healthy tissue through an incision in the breast. A separate incision in the armpit, or axilla, will be made to sample lymph nodes if a sentinel lymph node biopsy is required. The incisions will be closed with dissolving stitches under the skin and either strips of tape or surgical glue on the skin. A dressing will be applied and a surgical bra will be put on. In the recovery room you will be monitored and assessed for pain. Pain medication will be given so that pain is well controlled when you go home. You will go home with a prescription for a narcotic pain medicine. Pain Expect some degree of pain. Pain medication takes about 30 minutes to act and will be more effective if taken when you are experiencing less pain than if you wait until the pain is not tolerable. If you do not wish to take narcotic pain medication, you may take ibuprofen or acetaminophen. Please do not drive until you are no longer taking narcotic pain medicine. Incisions You may remove the top dressing on the first or second post-operative day. Leave the strips of tape or glue in place until they fall off or are removed by the doctor. If the edges of the tapes loosen, you may trim the edges with scissors. Place a gauze pad over the incisions if you have drainage or clothing is irritating. Wear a supportive, non-underwire bra for a few days and nights or until you are comfortable without it. -
Adolescent Hygiene Basics
Adolescent Hygiene Basics Puberty causes all kinds of changes in your body. Your skin and scalp may suddenly get oily very easily. Every day it seems you have new hair growing in different places. At times, you seem to sweat for no reason — and you may notice there are odors where you never had them before. What should you do about it? These bodily changes are a normal part of becoming an adult. Still, some of them can be a real source of anxiety. Who wants to worry about whether their underarms smell, anyway? Read below for information on some hygiene basics — and learn how to deal with greasy hair, perspiration, and body hair. Oily Hair The hormones that create acne are the same ones that can make you feel like you're suddenly styling your hair with a comb dipped in motor oil. Each strand of hair has its own sebaceous (oil) gland, which keeps the hair shiny and waterproof. But during puberty, when the sebaceous glands produce extra oil, it can make your hair look too shiny, oily, and greasy. Washing your hair every day or every other day can help control oily hair. Dozens of shampoos are available in drugstores and supermarkets for you to choose from — most brands are pretty similar, although you might want to try one that is specially formulated for oily hair. Use warm water and a small amount of shampoo to work up a lather. Don't scrub or rub too hard — this doesn't get rid of oil any better and can irritate your scalp or damage your hair.